Ask AI

Advancing Pharmacist Excellence in Solid Tumors: Essential Considerations for Expanding From IV to Subcutaneous ICIs

Enhance your understanding of current and emerging data on subcutaneous immune checkpoint inhibitors used to treat solid tumors to optimize patient-centered care through certified text modules and downloadable slides with notes.

Share

Program Content

Events

  • Live Event
    Advancing Pharmacist Excellence in Solid Tumors: Essential Considerations for Expanding From IV to Subcutaneous ICIs
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Subcutaneous ICI
Advancing Pharmacist Excellence in Solid Tumors: Essential Considerations for Expanding From IV to Subcutaneous Immune Checkpoint Inhibitors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2026

Provided by

ProCE Banner

Provided by ProCE, LLC.

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme LLC